Antiepileptic drugs in the preventive treatment of migraine in children and adolescents

Catello Vollono, Diana Ferraro, Massimiliano Valeriani

Research output: Contribution to journalArticle

Abstract

Migraine prevalence in childhood ranges from 2.7 to 10% causing a significant impact on quality of life. No drugs are currently approved for use in the prevention of pediatric migraine. Antiepileptic drugs such as valproate and topiramate have been approved for the preventive treatment of migraine in adults. The present study aimed at reviewing evidence on the efficacy and safety of antiepileptic drugs in the preventive treatment of migraine in children and adolescents. We searched PubMed from 1988 to May 2007 and reviewed, abstracted, and classified relevant literature. Thirteen studies were reviewed. Data from randomized controlled trials are available only for valproate and topiramate. They show that both topiramate and valproate are effective in reducing headache frequency, intensity, and duration. As for safety and tolerability, topiramate is well tolerated, while there are insufficient data regarding the tolerability of valproate. Open-label or retrospective studies suggest that levetiracetam, zonisamide, and gabapentin are effective, but further evidence is warranted to confirm these data.

Original languageEnglish
Pages (from-to)355-359
Number of pages5
JournalDrug Development Research
Volume68
Issue number6
DOIs
Publication statusPublished - Sep 2007

Fingerprint

Valproic Acid
Migraine Disorders
Anticonvulsants
etiracetam
zonisamide
Safety
Pediatrics
Therapeutics
PubMed
Headache
Labels
Randomized Controlled Trials
Retrospective Studies
Quality of Life
topiramate
Pharmaceutical Preparations

Keywords

  • Adolescents
  • Antiepileptic drugs
  • Children
  • Migraine
  • Prophylaxis

ASJC Scopus subject areas

  • Drug Discovery
  • Organic Chemistry
  • Pharmacology

Cite this

Antiepileptic drugs in the preventive treatment of migraine in children and adolescents. / Vollono, Catello; Ferraro, Diana; Valeriani, Massimiliano.

In: Drug Development Research, Vol. 68, No. 6, 09.2007, p. 355-359.

Research output: Contribution to journalArticle

@article{d8beef2eb2524b489ef34b25e10b693d,
title = "Antiepileptic drugs in the preventive treatment of migraine in children and adolescents",
abstract = "Migraine prevalence in childhood ranges from 2.7 to 10{\%} causing a significant impact on quality of life. No drugs are currently approved for use in the prevention of pediatric migraine. Antiepileptic drugs such as valproate and topiramate have been approved for the preventive treatment of migraine in adults. The present study aimed at reviewing evidence on the efficacy and safety of antiepileptic drugs in the preventive treatment of migraine in children and adolescents. We searched PubMed from 1988 to May 2007 and reviewed, abstracted, and classified relevant literature. Thirteen studies were reviewed. Data from randomized controlled trials are available only for valproate and topiramate. They show that both topiramate and valproate are effective in reducing headache frequency, intensity, and duration. As for safety and tolerability, topiramate is well tolerated, while there are insufficient data regarding the tolerability of valproate. Open-label or retrospective studies suggest that levetiracetam, zonisamide, and gabapentin are effective, but further evidence is warranted to confirm these data.",
keywords = "Adolescents, Antiepileptic drugs, Children, Migraine, Prophylaxis",
author = "Catello Vollono and Diana Ferraro and Massimiliano Valeriani",
year = "2007",
month = "9",
doi = "10.1002/ddr.20201",
language = "English",
volume = "68",
pages = "355--359",
journal = "Drug Development Research",
issn = "0272-4391",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Antiepileptic drugs in the preventive treatment of migraine in children and adolescents

AU - Vollono, Catello

AU - Ferraro, Diana

AU - Valeriani, Massimiliano

PY - 2007/9

Y1 - 2007/9

N2 - Migraine prevalence in childhood ranges from 2.7 to 10% causing a significant impact on quality of life. No drugs are currently approved for use in the prevention of pediatric migraine. Antiepileptic drugs such as valproate and topiramate have been approved for the preventive treatment of migraine in adults. The present study aimed at reviewing evidence on the efficacy and safety of antiepileptic drugs in the preventive treatment of migraine in children and adolescents. We searched PubMed from 1988 to May 2007 and reviewed, abstracted, and classified relevant literature. Thirteen studies were reviewed. Data from randomized controlled trials are available only for valproate and topiramate. They show that both topiramate and valproate are effective in reducing headache frequency, intensity, and duration. As for safety and tolerability, topiramate is well tolerated, while there are insufficient data regarding the tolerability of valproate. Open-label or retrospective studies suggest that levetiracetam, zonisamide, and gabapentin are effective, but further evidence is warranted to confirm these data.

AB - Migraine prevalence in childhood ranges from 2.7 to 10% causing a significant impact on quality of life. No drugs are currently approved for use in the prevention of pediatric migraine. Antiepileptic drugs such as valproate and topiramate have been approved for the preventive treatment of migraine in adults. The present study aimed at reviewing evidence on the efficacy and safety of antiepileptic drugs in the preventive treatment of migraine in children and adolescents. We searched PubMed from 1988 to May 2007 and reviewed, abstracted, and classified relevant literature. Thirteen studies were reviewed. Data from randomized controlled trials are available only for valproate and topiramate. They show that both topiramate and valproate are effective in reducing headache frequency, intensity, and duration. As for safety and tolerability, topiramate is well tolerated, while there are insufficient data regarding the tolerability of valproate. Open-label or retrospective studies suggest that levetiracetam, zonisamide, and gabapentin are effective, but further evidence is warranted to confirm these data.

KW - Adolescents

KW - Antiepileptic drugs

KW - Children

KW - Migraine

KW - Prophylaxis

UR - http://www.scopus.com/inward/record.url?scp=38149074776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38149074776&partnerID=8YFLogxK

U2 - 10.1002/ddr.20201

DO - 10.1002/ddr.20201

M3 - Article

AN - SCOPUS:38149074776

VL - 68

SP - 355

EP - 359

JO - Drug Development Research

JF - Drug Development Research

SN - 0272-4391

IS - 6

ER -